Press Release Recent Transaction: Santen Inc. signs two floor lease in Emeryville
April 11, 2011

Mihalovich Partners is pleased to announce that, on behalf of Santen Inc., we have negotiated and completed a 50,000 square foot lease at 2100 Powell Street in Emeryville.

2100 Powell Street, Emeryville 2100 Powell Street, Emeryville
Entire 15th & 16 Floor—50,000 square feet

San Francisco—Santen Inc., a wholly-owned subsidiary of Santen Pharmaceutical Co., Ltd., Osaka, Japan, currently located in Napa, has signed a new long-term lease for the entire 15th and 16th floors of 2100 Powell Street, Emeryville. 2100 Powell is owned and managed by Hines and was recently certified LEED Gold. Santen will relocate its U.S. corporate headquarters to 2100 Powell in early July 2011.

“In the preparation of our new strategic plan we can see that there will be substantial expansion of the organization and we could not have accommodated this growth in the existing facility in Napa,” stated Akihiro Tsujimura, Chief Operating Officer (COO) of Santen Inc. “Since we will experience a significant demand for new staff we believe that the new location will make it easier to recruit the highest quality talent as we will have increased access to the greater San Francisco Bay Area bio-pharmaceutical talent pool.”

In addition, it was noted that the increased interaction between the Company’s Japanese and European colleagues was a secondary driving force behind the relocation, seeking a more convenient location for international transportation.

“Emeryville provides an excellent centralized location that provides easy access to both Oakland and San Francisco airports which will facilitate increased collaboration between our corporate and regional R&D organizations. Collaboration among our regional R&D organizations is a cornerstone of our strategy to accelerate our clinical development timelines,” said Toshiaki Nishihata PhD, President and CEO of Santen Inc. “From this site we also have easy access to UC San Francisco, UC Berkeley and Stanford, rich sources of intellectual capital and support for our R&D initiatives.”

Dan Mihalovich, broker for Santen, echoed the sentiments about Emeryville. “We conducted an exhaustive comparative study of alternative buildings for our client in the East Bay and Peninsula markets. Our negotiations with Hines proved out that 2100 Powell offered the most attractive combination of high quality and efficient space; compelling economics; spectacular amenities; and first class building ownership and management. Our Team, which included Huntsman Architectural Group and Principal Builders, developed a terrific fit for Santen and anticipate an optimal environment for them to succeed in this new U.S. headquarters facility.”

About Santen Inc.
Santen Inc., currently based in Napa, California, is the U.S. subsidiary of Santen Pharmaceutical Co., Ltd., a billion-dollar global company headquartered in Osaka, Japan since 1890. Santen researches, develops and markets ophthalmic products for physicians worldwide. Santen has subsidiaries in the U.S., Europe and Asia, including its wholly-owned Napa, California-based Santen Inc. Santen Inc. also maintains a satellite business development office in Irvine, California which provides direct access to the regional cluster of ophthalmic companies operating in that area. Among prescription ophthalmic pharmaceuticals, Santen holds the top share within the Japanese and Chinese markets and is one of the leading ophthalmic companies worldwide. Santen’s global product pipeline includes a number of prescription pharmaceuticals in varying clinical trial phases. A detailed listing, as well as additional corporate information, is available online at

Mihalovich Partners, a San Francisco based tenant-representation firm, was formed in 1998 by Dan Mihalovich. Mr. Mihalovich brings to the firm over 31 years of business experience, focusing on market analysis, negotiation skills and project management expertise. He has managed over 200 office-leasing assignments for many of the Bay Area’s most prestigious tenants. His career, and the focus of Mihalovich Partners, is solely driven to advocate the interests of tenants in leasing negotiations of all types—renewals, relocations, renegotiations, and terminations. To avoid conflicts of interest, unlike most firms in the leasing brokerage business, Mihalovich Partners never represents landlords.

Visit our website at to learn more.

Dan Mihalovich
505 Montgomery Street, Suite 1100
San Francisco, CA 94111
T: 415-434-2820
F: 415-434-2830

« back to all press releases

Bookmark and Share